Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galectin Therapeutics, Inc.
NEW YORK, July 30, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin Therapeutics, Inc. ("Galectin Therapeutics" or the "Company") (NasdaqCM: GALT). Such investors are advised to contact Edward N. Gewirtz or his investor relation's coordinator Eitan Kimelman at [email protected] or 212-697-6484.
The investigation focuses on whether the Company and certain of its executives violated federal securities laws.
On Monday, July 28, 2014, Adam Feurstein of TheStreet.com wrote an article alleging that Galectin Therapeutics hired a stock promotions firm to tout its stock. Then on July 29, 2014, Galectin reported Phase 1 results on its liver experimental drug GR-MD-02 showing little difference from a placebo in its Phase 1 study.
On this news, shares of Galectin Therapeutics fell $8.84 or 60.08% to close at $5.70 on July 29, 2014.
If you are aware of any facts relating to this investigation, or purchased shares of Galectin Therapeutics you can assist this investigation by contacting Edward N. Gewirtz or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Edward N. Gewirtz or Eitan Kimelman 212-697-6484
[email protected]
SOURCE Bronstein, Gewirtz & Grossman, LLC
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article